121 results on '"Aldape, Kenneth"'
Search Results
2. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
3. Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma.
4. A novel ARIH1::BRAF fusion in a glioma.
5. An incidental finding of a high-grade glioma with pleomorphic and pseudopapillary features (HPAP) with PBRM1 mutation.
6. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
7. ZFTA-fused supratentorial ependymoma with a novel fusion partner, DUX4.
8. An unusual case of metastatic diffuse midline glioma in an adult.
9. Introduction: Ongoing clinical challenges in the management of meningiomas and future directions.
10. Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas.
11. First-time identification of a KIF5B-NTRK2 fusion in extraventricular neurocytoma.
12. Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
13. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
14. Consensus core clinical data elements for meningiomas (v2021.1).
15. molecularly integrated grade for meningioma.
16. DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
17. DNA methylation profiling and histologic analysis of sellar TTF-1-positive papillary epithelial tumor supports a novel CNS entity.
18. Glioblastoma, IDH-Wildtype Harboring a KIAA1549::BRAF Fusion: Report of a Case With Comprehensive Molecular Profiling.
19. DNA methylation profiling as a model for discovery and precision diagnostics in neuro-oncology.
20. Atypical neurofibromatous lesions: Epigenetic cousins of other benign peripheral nerve sheath tumors?
21. Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.
22. Loss of H3K27me3 in meningiomas.
23. Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis.
24. A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
25. CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
26. Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants.
27. Highlights from the literature.
28. Highlights from the Literature.
29. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
30. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.
31. 892 Validation of Docetaxel as a Radiosensitizer in High-Risk Meningiomas Based on DNA Methylation Profiling.
32. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms.
33. Proteomic analysis of meningiomas reveals clinically distinct molecular patterns.
34. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges.
35. Imaging and diagnostic advances for intracranial meningiomas.
36. Molecular and translational advances in meningiomas.
37. Advances in multidisciplinary therapy for meningiomas.
38. A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
39. Highlights from the Literature.
40. Highlights from the Literature.
41. Highlights from the Literature.
42. Highlights from the Literature.
43. Highlights from the Literature.
44. Highlights from the Literature.
45. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium.
46. Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma.
47. Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community.
48. Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813.
49. Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.
50. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.